Literature DB >> 8064213

Behavioral and pharmacological modulation of respiration in rhesus monkeys.

L L Howell1, A M Landrum.   

Abstract

Changes in respiration associated with schedule-controlled behavior were determined in seated rhesus monkeys prepared with a pressure-displacement head plethysmograph for monitoring ventilation continuously during behavioral experiments. Subjects were trained to press a lever under fixed-ratio 40 and fixed-interval 300-s schedules of stimulus termination. Episodic increases in ventilation were closely associated with periods of responding under both schedules. Recurring episodes of increased ventilation occurred during fixed-ratio responding, and were separated by brief 10-s timeouts during which ventilation decreased. Under the fixed-interval schedule, both ventilation and response rate typically increased as the 300-s interval elapsed. The effects of cocaine, caffeine, and two adenosine agonists, 5'-N-ethylcarboxamidadenosine (NECA) and 2-(carboxyethylphenylamino)adenosine-5'-carboxamide (CGS 21680), on behavior and respiration were determined using a cumulative-dosing procedure. Drug-induced suppression of behavior eliminated the episodic increases in ventilation during the performance components of both schedules. Schedule-related increases in ventilation were compared to those produced by elevated levels of CO2 in inspired air. Exposure to 4% CO2 mixed in air increased ventilation in all subjects, and the combined effects of CO2 exposure and schedule-controlled responding on respiration appeared to be additive. The results suggest that behavioral activities may increase ventilation through increased metabolic demand and increased CO2 production.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8064213      PMCID: PMC1334367          DOI: 10.1901/jeab.1994.62-57

Source DB:  PubMed          Journal:  J Exp Anal Behav        ISSN: 0022-5002            Impact factor:   2.468


  30 in total

1.  Cocaine receptors on dopamine transporters are related to self-administration of cocaine.

Authors:  M C Ritz; R J Lamb; S R Goldberg; M J Kuhar
Journal:  Science       Date:  1987-09-04       Impact factor: 47.728

2.  Dose effect of caffeine on control of breathing and respiratory response to CO2 in cats.

Authors:  M Mazzarelli; N Jaspar; W A Zin; J V Aranda; J Milic-Emili
Journal:  J Appl Physiol (1985)       Date:  1986-01

3.  Conditioned neuronal responses at various levels in conditioning paradigms.

Authors:  E S Halas; J V Beardsley; M E Sandlie
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1970-05

Review 4.  Adenosine receptors in the central nervous system: relationship to the central actions of methylxanthines.

Authors:  J W Daly; R F Bruns; S H Snyder
Journal:  Life Sci       Date:  1981-05-11       Impact factor: 5.037

Review 5.  The neuropharmacology of respiratory control.

Authors:  R A Mueller; D B Lundberg; G R Breese; J Hedner; T Hedner; J Jonason
Journal:  Pharmacol Rev       Date:  1982-09       Impact factor: 25.468

6.  Effects of propranolol, phentolamine and methyl atropine on cardiovascular function in the squirrel monkey during behavioral experiments.

Authors:  R T Kelleher; W H Morse; J A Herd
Journal:  J Pharmacol Exp Ther       Date:  1972-08       Impact factor: 4.030

7.  Psychomotor stimulant effects of methylxanthines in squirrel monkeys: relation to adenosine antagonism.

Authors:  R D Spealman
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

8.  Aminophylline may stimulate respiration in rats by activation of dopaminergic receptors.

Authors:  D B Lundberg; G R Breese; R A Mueller
Journal:  J Pharmacol Exp Ther       Date:  1981-04       Impact factor: 4.030

9.  Caffeine effect on breathing pattern and vagal reflexes in newborn rabbits.

Authors:  T Trippenbach; R Zinman; J Milic-Emili
Journal:  Respir Physiol       Date:  1980-05

10.  Adenosine receptors and behavioral actions of methylxanthines.

Authors:  S H Snyder; J J Katims; Z Annau; R F Bruns; J W Daly
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.